Crescent Capital BDC (CCAP) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
9 Jul, 2026Executive summary
Reported Q4 2024 net investment income of $0.55 per share and net income of $0.27 per share; full-year NII was $2.40 per share and net income $1.99 per share.
Net asset value (NAV) per share was $19.98 at year-end, reflecting stability and resilience.
Portfolio diversified across 185 companies in 20 industries, with 90% in first-lien or unitranche loans.
Declared Q1 2025 regular dividend of $0.42 per share and three $0.05 special dividends for undistributed taxable income.
Total assets at year-end were $1.66B, with net assets of $740.6M.
Financial highlights
Q4 2024 investment income was $46.4M, down from $51.6M in Q3, primarily due to lower benchmark rates.
Full-year 2024 investment income rose to $197.4M from $184.1M in 2023, driven by portfolio growth and one-time income.
Total expenses for 2024 were $108.4M, up from $101.6M in 2023, mainly due to higher debt financing costs.
Debt-to-equity ratio increased to 1.19x at year-end, within the target range.
Weighted average yield on income-producing securities was 10.9% in Q4 2024.
Outlook and guidance
Board declared a Q1 2025 regular dividend of $0.42 per share and three special dividends of $0.05 per share each.
Expects further decline in interest income in Q1 2025 due to full-quarter impact of rate cuts.
Portfolio strategy remains conservative, emphasizing first lien loans and defensive positioning.
Anticipates increased M&A and LBO activity in 2025, supported by favorable economic and regulatory conditions.
Maintains disciplined credit underwriting and focus on capital preservation amid stable economic indicators.
Latest events from Crescent Capital BDC
- Q2 2024 NII reached $0.59/share, NAV hit $20.30, with strong liquidity and low nonaccruals.CCAP
Q2 20248 Jul 2026 - Directors were elected for three-year terms and the auditor was ratified with no shareholder questions.CCAP
AGM 202621 May 2026 - Net investment income and NAV per share declined, with fee reductions and special dividends announced.CCAP
Q1 202614 May 2026 - Net investment income per share was $0.46 for Q3 2025, with NAV per share at $19.28.CCAP
Q3 20256 May 2026 - Q4 net investment income covered the dividend, with NAV at $19.10 and a strong, diversified portfolio.CCAP
Q4 20256 Apr 2026 - Virtual meeting to elect directors and ratify auditor, with online voting available.CCAP
Proxy filing1 Apr 2026 - Virtual meeting to elect directors and ratify E&Y as auditor, with strong governance oversight.CCAP
Proxy filing1 Apr 2026 - Q3 net investment income rose to $0.64 per share, with strong liquidity and low non-accruals.CCAP
Q3 202414 Jan 2026 - Board urges ratification of Ernst & Young LLP as auditor, with 2024 fees totaling $841,150.CCAP
Proxy Filing2 Dec 2025